Community and hospital pharmacy and industrial pharmacy specialisation programmes, students starting on 1 August 2026
Students who start their studies on 1 August 2026 will complete their studies according to the new 2026–2030 curriculum.
The scope of optional studies is 5 credits for Bachelor of Science (Pharmacy) degree holders and 10 credits for Master of Science (Pharmacy) degree holders. The scope of the programme and the structure of studies are in accordance with the new curriculum (2026–2030).
Recommended study paths in the community and hospital pharmacy and industrial pharmacy specialisation programmes for those who started on 1 August 2025 and earlier
Students who started their studies on 1 August 2025 will complete their studies as follows:
In the academic year 2025–2026, according to the old curriculum (2023–2026):
- Leadership studies, 6 credits
- Research and evaluation methods, 1 / 4 credits
- Development project, 8 / 20 credits
From the academic year 2026–2027 onwards, according to the new curriculum (2026–2030):
- Development of medication safety and risk management within social and healthcare (compulsory in community and hospital pharmacy; replaces the separate courses Medication Safety and High risk medicines), 5 credits
- Optional studies
The scope of optional studies is 10 credits for Bachelor of Science (Pharmacy) degree holders and 15 credits for Master of Science (Pharmacy) degree holders; in the residency path 11 and 16 credits. The scope of the programme and the structure of studies are in accordance with the old curriculum (2023–2026).
Students who started their studies on 1 August 2024 will complete their studies as follows:
In the academic year 2025–2026, according to the old curriculum (2023–2026):
- Leadership studies, 5 credits
- Research and evaluation methods, 1 / 4 credits
- Development project, 8 / 20 credits
From the academic year 2026–2027 onwards, according to the new curriculum (2026–2030):
The scope of optional studies is 10 credits for Bachelor of Science (Pharmacy) degree holders and 15 credits for Master of Science (Pharmacy) degree holders; in the residency path 11 and 16 credits. The scope of the programme and the structure of studies are in accordance with the old curriculum (2023–2026).
Students who started on 1 August 2023 and earlier will complete their studies as follows:
From the academic year 2026–2027 onwards, according to the new curriculum (2026–2030):
The scope of optional studies is 10 credits for Bachelor of Science (Pharmacy) degree holders and 15 credits for Master of Science (Pharmacy) degree holders; in the residency path 11 and 16 credits. The scope of the programme and the structure of studies are in accordance with the old curriculum (2023–2026 or earlier).
Transition policies
Students in the pharmacy specialisation programmes who started on 1 August 2025 or earlier may complete their remaining studies as described above (recommended study path) or transfer entirely to the new curriculum. Transfer is by application and is possible from 1 August 2026. Upon transfer, the student may have previously completed studies in their original programme recognised to the extent applicable. The transfer does not affect the granted study time.
The transition period ends on 31 July 2030. Students who have registered as present or absent, whose right to study is valid, and who have not, within the transition period, transferred to the new curriculum or graduated from the specialisation education under the previous curriculum period, will be transferred automatically to the new curriculum on 1 August 2030. There is therefore ample time to graduate under the previous curriculum period.
For those who start their studies under the new curriculum and those who transfer entirely to the new curriculum, the tuition fee is €120 per credit. For those who started under the previous curriculum and proceed according to the recommended study path, the tuition fee is €100 per credit.